Japan's Takeda clinches $62 billion deal to buy drugmaker Shire

LONDON/TOKYO (Reuters) - Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($61.50 billion) on Tuesday after the Japanese company raised the amount of cash in its offer to secure a recommendation.

Japan's Takeda clinches $62 billion deal to buy drugmaker Shire
Read More


Bagikan Berita Ini